Halozyme Therapeutics Inc (HALO) — Strategic Asset Allocation Index
Halozyme Therapeutics Inc (HALO) has a Strategic Asset Allocation Index of 30.0% as of September 2023. Strategic assets (PP&E of $74.67 Million plus long-term investments of $-) total $74.67 Million, measured against net assets of $249.18 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Halozyme Therapeutics Inc Strategic Asset Allocation Index (2004–2022)
This chart shows how Halozyme Therapeutics Inc's Strategic Asset Allocation Index has evolved across 17 annual periods from 2004 to 2022. As of September 2023, the index stands at 30.0%, representing strategic assets of $74.67 Million against net assets of $249.18 Million USD. Explore Halozyme Therapeutics Inc (HALO) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Halozyme Therapeutics Inc (2004–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Halozyme Therapeutics Inc from 2004 to 2022, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Halozyme Therapeutics Inc (HALO) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 44.5% | $75.57 Million | $75.57 Million | $- | $169.80 Million | ▲ +40.0 pp |
| 2021 | 4.5% | $8.79 Million | $8.79 Million | $- | $196.95 Million | ▼ -2.5 pp |
| 2020 | 7.0% | $10.59 Million | $10.59 Million | $- | $151.05 Million | ▼ -4.8 pp |
| 2019 | 11.8% | $10.86 Million | $10.86 Million | $- | $91.77 Million | ▲ +8.8 pp |
| 2018 | 3.0% | $7.46 Million | $7.46 Million | $- | $248.89 Million | ▲ +1.3 pp |
| 2017 | 1.7% | $3.52 Million | $3.52 Million | $- | $208.37 Million | ▼ -7.5 pp |
| 2015 | 9.2% | $3.94 Million | $3.94 Million | $- | $43.00 Million | ▲ +2.0 pp |
| 2014 | 7.1% | $2.95 Million | $2.95 Million | $- | $41.35 Million | ▼ -0.4 pp |
| 2012 | 7.6% | $3.70 Million | $3.70 Million | $- | $48.85 Million | ▼ -8.7 pp |
| 2011 | 16.2% | $1.77 Million | $1.77 Million | $- | $10.90 Million | ▲ +7.2 pp |
| 2010 | 9.1% | $1.85 Million | $1.85 Million | $- | $20.35 Million | ▼ -30.2 pp |
| 2009 | 39.2% | $2.71 Million | $2.71 Million | $- | $6.90 Million | ▲ +22.6 pp |
| 2008 | 16.6% | $2.55 Million | $2.55 Million | $- | $15.38 Million | ▲ +12.6 pp |
| 2007 | 4.0% | $2.28 Million | $2.28 Million | $- | $57.77 Million | ▲ +1.8 pp |
| 2006 | 2.2% | $497.00K | $497.00K | $- | $23.08 Million | ▲ +0.1 pp |
| 2005 | 2.1% | $381.00K | $381.00K | $- | $18.21 Million | ▲ +0.5 pp |
| 2004 | 1.6% | $235.00K | $235.00K | $- | $14.82 Million | — |